Success Metrics

Clinical Success Rate
83.9%

Based on 78 completed trials

Completion Rate
84%(78/93)
Active Trials
24(18%)
Results Posted
60%(47 trials)
Terminated
15(11%)

Phase Distribution

Ph phase_3
33
24%
Ph not_applicable
69
50%
Ph phase_1
8
6%
Ph phase_2
22
16%
Ph phase_4
4
3%

Phase Distribution

8

Early Stage

22

Mid Stage

37

Late Stage

Phase Distribution136 total trials
Phase 1Safety & dosage
8(5.9%)
Phase 2Efficacy & side effects
22(16.2%)
Phase 3Large-scale testing
33(24.3%)
Phase 4Post-market surveillance
4(2.9%)
N/ANon-phased studies
69(50.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

78 of 96 finished

Non-Completion Rate

18.8%

18 ended early

Currently Active

24

trials recruiting

Total Trials

137

all time

Status Distribution
Active(27)
Completed(78)
Terminated(18)
Other(14)

Detailed Status

Completed78
Recruiting16
Terminated15
unknown13
Active, not recruiting8
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
137
Active
24
Success Rate
83.9%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (5.9%)
Phase 222 (16.2%)
Phase 333 (24.3%)
Phase 44 (2.9%)
N/A69 (50.7%)

Trials by Status

not_yet_recruiting32%
unknown139%
withdrawn32%
suspended11%
active_not_recruiting86%
completed7857%
recruiting1612%
terminated1511%

Recent Activity

Clinical Trials (137)

Showing 20 of 137 trialsScroll for more
NCT05984238Not Applicable

A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy

Completed
NCT06092476Not Applicable

Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

Active Not Recruiting
NCT06267391Not Applicable

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

Active Not Recruiting
NCT06176352Phase 3

A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Completed
NCT02439775Not Applicable

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

Completed
NCT07605429Phase 3

BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.

Recruiting
NCT04967170Phase 1

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

Completed
NCT06635148Phase 2

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Recruiting
NCT07233083Not Applicable

External Oblique Intercostal Plane Block for Liver Transplantation Recipient

Completed
NCT07444450Phase 3

A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

Not Yet Recruiting
NCT07165041Not Applicable

Serratus Posterior Superior Intercostal Plane Block in Cardiac Implantable Electronic Device Implantation

Completed
NCT05686317Not Applicable

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

Active Not Recruiting
NCT06066645Phase 4

Travoprost Intraocular Implant + iStent Infinite

Recruiting
NCT07504640Not Applicable

The Effect of Spinal Manipulation on Heart Rate Variability in Children With Cerebral Palsy.

Recruiting
NCT05685134Not Applicable

Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome

Completed
NCT07331220Not Applicable

Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction

Not Yet Recruiting
NCT05769153Phase 1

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Active Not Recruiting
NCT04122703Not Applicable

Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction

Completed
NCT05151731Phase 2

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Completed
NCT07083765Phase 3

Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

Suspended

Drug Details

Intervention Type
OTHER
Total Trials
137